volume 8 issue 5 pages 945-955

New aromatase inhibitors. Synthesis and biological activity of aryl-substituted pyrrolizine and indolizine derivatives

Pascal Sonnet 1
Patrick Dallemagne 2
J. M. Guillon 2
Cécile ENGUEHARD 2
Silvia Stiebing 2
Julien Tanguy 2
Ronan Bureau 2
Sylvain Rault 2
Pierrı̈ck Auvray 3
Safa Moslemi 3
Pascal Sourdaine 3
Gilles-Eric Séralini 3
1
 
Centre d'Etudes et de Recherche sur le Médicament de Normandie, Laboratoire de Pharmacochimie, UFR des Sciences Pharmaceutiques, Caen, France.
2
 
Centre d'Etudes et de Recherche sur le Médicament de Normandie, Laboratoire de Pharmacochimie, UFR des Sciences Pharmaceutiques, 1, rue Vaubénard, 14032 Caen Cedex, France
3
 
IBBA, Laboratoire de Biochimie et Biologie Moléculaire Esplanade de la Paix, 14032 Caen Cedex, France
Publication typeJournal Article
Publication date2000-05-01
scimago Q2
wos Q1
SJR0.608
CiteScore6.7
Impact factor3.0
ISSN09680896, 14643391
Organic Chemistry
Drug Discovery
Biochemistry
Molecular Biology
Pharmaceutical Science
Clinical Biochemistry
Molecular Medicine
Abstract
We report herein the design and the synthesis of some aryl-substituted pyrrolizine and indolizine derivatives, on the basis of a hypothetical pharmacophore structure designed to fit the catalytic site of the human cytochrome P450 aromatase. The in vitro biological evaluation of these compounds allowed us to point out two new potent non-steroidal aromatase inhibitors, MR 20494 and MR 20492, with IC50 values in the range of 0.1 microM.
Found 
Found 

Top-30

Journals

1
2
3
4
5
6
7
8
European Journal of Medicinal Chemistry
8 publications, 6.9%
Tetrahedron
7 publications, 6.03%
Acta Crystallographica Section E Structure Reports Online
5 publications, 4.31%
ChemistrySelect
5 publications, 4.31%
Journal of Organic Chemistry
5 publications, 4.31%
European Journal of Organic Chemistry
4 publications, 3.45%
Tetrahedron Letters
3 publications, 2.59%
Advanced Synthesis and Catalysis
3 publications, 2.59%
Organic Letters
3 publications, 2.59%
RSC Advances
3 publications, 2.59%
Tetrahedron Asymmetry
2 publications, 1.72%
Molecules
2 publications, 1.72%
Medicinal Chemistry Research
2 publications, 1.72%
Bioorganic and Medicinal Chemistry Letters
2 publications, 1.72%
Mendeleev Communications
2 publications, 1.72%
Journal of Heterocyclic Chemistry
2 publications, 1.72%
Journal of Combinatorial Chemistry
2 publications, 1.72%
Organic and Biomolecular Chemistry
2 publications, 1.72%
Chemical Communications
2 publications, 1.72%
Synthetic Communications
2 publications, 1.72%
Heterocycles
2 publications, 1.72%
Synthesis
2 publications, 1.72%
Chemistry and Biodiversity
2 publications, 1.72%
Current Enzyme Inhibition
1 publication, 0.86%
Advanced Drug Delivery Reviews
1 publication, 0.86%
Organic Preparations and Procedures International
1 publication, 0.86%
MolBank
1 publication, 0.86%
Catalysts
1 publication, 0.86%
Journal of Chemical Crystallography
1 publication, 0.86%
1
2
3
4
5
6
7
8

Publishers

5
10
15
20
25
30
35
Elsevier
33 publications, 28.45%
Wiley
24 publications, 20.69%
American Chemical Society (ACS)
14 publications, 12.07%
Royal Society of Chemistry (RSC)
9 publications, 7.76%
Springer Nature
8 publications, 6.9%
Taylor & Francis
6 publications, 5.17%
International Union of Crystallography (IUCr)
5 publications, 4.31%
MDPI
4 publications, 3.45%
Bentham Science Publishers Ltd.
2 publications, 1.72%
OOO Zhurnal "Mendeleevskie Soobshcheniya"
2 publications, 1.72%
The Japan Institute of Heterocyclic Chemistry
2 publications, 1.72%
Georg Thieme Verlag KG
2 publications, 1.72%
Pleiades Publishing
1 publication, 0.86%
Beilstein-Institut
1 publication, 0.86%
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 0.86%
Turkish Chemical Society
1 publication, 0.86%
5
10
15
20
25
30
35
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
116
Share
Cite this
GOST |
Cite this
GOST Copy
Sonnet P. et al. New aromatase inhibitors. Synthesis and biological activity of aryl-substituted pyrrolizine and indolizine derivatives // Bioorganic and Medicinal Chemistry. 2000. Vol. 8. No. 5. pp. 945-955.
GOST all authors (up to 50) Copy
Sonnet P., Dallemagne P., Guillon J. M., ENGUEHARD C., Stiebing S., Tanguy J., Bureau R., Rault S., Auvray P., Moslemi S., Sourdaine P., Séralini G. New aromatase inhibitors. Synthesis and biological activity of aryl-substituted pyrrolizine and indolizine derivatives // Bioorganic and Medicinal Chemistry. 2000. Vol. 8. No. 5. pp. 945-955.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/S0968-0896(00)00024-9
UR - https://doi.org/10.1016/S0968-0896(00)00024-9
TI - New aromatase inhibitors. Synthesis and biological activity of aryl-substituted pyrrolizine and indolizine derivatives
T2 - Bioorganic and Medicinal Chemistry
AU - Sonnet, Pascal
AU - Dallemagne, Patrick
AU - Guillon, J. M.
AU - ENGUEHARD, Cécile
AU - Stiebing, Silvia
AU - Tanguy, Julien
AU - Bureau, Ronan
AU - Rault, Sylvain
AU - Auvray, Pierrı̈ck
AU - Moslemi, Safa
AU - Sourdaine, Pascal
AU - Séralini, Gilles-Eric
PY - 2000
DA - 2000/05/01
PB - Elsevier
SP - 945-955
IS - 5
VL - 8
PMID - 10882007
SN - 0968-0896
SN - 1464-3391
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2000_Sonnet,
author = {Pascal Sonnet and Patrick Dallemagne and J. M. Guillon and Cécile ENGUEHARD and Silvia Stiebing and Julien Tanguy and Ronan Bureau and Sylvain Rault and Pierrı̈ck Auvray and Safa Moslemi and Pascal Sourdaine and Gilles-Eric Séralini},
title = {New aromatase inhibitors. Synthesis and biological activity of aryl-substituted pyrrolizine and indolizine derivatives},
journal = {Bioorganic and Medicinal Chemistry},
year = {2000},
volume = {8},
publisher = {Elsevier},
month = {may},
url = {https://doi.org/10.1016/S0968-0896(00)00024-9},
number = {5},
pages = {945--955},
doi = {10.1016/S0968-0896(00)00024-9}
}
MLA
Cite this
MLA Copy
Sonnet, Pascal, et al. “New aromatase inhibitors. Synthesis and biological activity of aryl-substituted pyrrolizine and indolizine derivatives.” Bioorganic and Medicinal Chemistry, vol. 8, no. 5, May. 2000, pp. 945-955. https://doi.org/10.1016/S0968-0896(00)00024-9.